Competition in the Global Hemostasis Valve Market

Published: Aug 2019

The global hemostasis valves market is competitive in nature with the presence of several players operating in the market. The players are trying to enhance their geographical presence by expanding geographically. In addition, the players operating in the hemostasis valve industry are launching new products in the market to strengthen their existing product line and increasing the revenue share in the market. Further, the players are also taking over other firms in order to cut the competition and enhance their customer base.

Read the full report description of "Hemostasis Valve Market by Type (Y-Connector, Double Y-Connector, and One-Handed), By Application (Angiography and Angioplasty) - Global Industry Share, Growth, Competitive Analysis and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/hemostasis-valve-market


PhD Polycarbonate Hemostasis Valve in the US - Merit Medical Systems, Inc.

In May 2019, Merit Medical Systems, Inc. announced the launch of its PhD (“Push, Hold, Deliver”) polycarbonate hemostasis control valve, in the US. The dual-seal PhD device has been available in European markets since 2014. The product has experienced significant success in the European market, with unit sales averaging 34% year-over-year growth. In the US, the company will offer the device as a stand-alone or in combination with Merit’s suite of inflation devices and custom kits.

New Medical Production Facilities in Penang - B. Braun

In April 2018, B. Braun officially introduced 5 new production plants and other administrative buildings in Penang, Malaysia. Built over a period of 9 years, these new manufacturing facilities comprises the latest building and production technologies. These manufacturing facilities are opened for the manufacturing of medical devices for infusion therapy, pharmaceutical solutions and surgical instruments for the treatment of patients in Malaysia and across the globe.

New Family of Hemostasis Valves for Interventional and Diagnostic Catheters - Freudenberg Medical

In October 2017, Freudenberg Medical introduced new hemostasis valve family adds the innovative HyperSeal and CertuSeal valves to FlexSeal valve launched in 2016 by the company. Hemostasis valves are used for minimizing blood loss. In addition, these valves can facilitate minimally invasive and catheter-based medical procedures. The hemostasis valves launched by the company are designed for improving hemostasis and procedural performance.

Qosina Adds New Y Connector Hemostasis Valves

In January 2017, Qosina announced the addition of four new Y connector hemostasis valves to its product line. With this launch, the company has strengthened its product line and has availed various options for its customers. The company offers a wide range of double and one-handed hemostasis valves. In addition, the company offers a wide range of guide wire and catheter accessories such as torquers, dispensing tubing and channel clips.

Global Hemostasis Valve Market- Segmentation

By Type

  • Y-connector
  • Double Y-connector
  • One-handed

By Application

  • Angiography
  • Angioplasty


Global Hemostasis Valve Market – Segment by Region

North America           

  • US
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific    

  • China
  •  Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa
  • Latin America


To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hemostasis-valve-market